Clinical Trial Update: A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 comparative trial evaluating paliperidone palmitate versus risperidone long-acting injection in adults with schizophrenia; results completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)
• Risperidone Long Acting Injection (risperidone long-acting injectable)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-07-10